These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
390 related articles for article (PubMed ID: 32633782)
1. Novel prognostic prediction model constructed through machine learning on the basis of methylation-driven genes in kidney renal clear cell carcinoma. Tang W; Cao Y; Ma X Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32633782 [TBL] [Abstract][Full Text] [Related]
2. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis. Hu F; Zeng W; Liu X Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630 [TBL] [Abstract][Full Text] [Related]
3. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients. Yu J; Mao W; Xu B; Chen M Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306 [TBL] [Abstract][Full Text] [Related]
4. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma. Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607 [TBL] [Abstract][Full Text] [Related]
5. Identifying prognostic biomarkers based on aberrant DNA methylation in kidney renal clear cell carcinoma. Chen G; Wang Y; Wang L; Xu W Oncotarget; 2017 Jan; 8(3):5268-5280. PubMed ID: 28029655 [TBL] [Abstract][Full Text] [Related]
6. Cuproptosis gene-related, neural network-based prognosis prediction and drug-target prediction for KIRC. Liu Y; Shao Y; Hao Z; Lei X; Liang P; Chang Q; Wang X Cancer Med; 2024 Jan; 13(1):e6763. PubMed ID: 38131663 [TBL] [Abstract][Full Text] [Related]
7. Alternative splicing associated with cancer stemness in kidney renal clear cell carcinoma. Xiao L; Zou G; Cheng R; Wang P; Ma K; Cao H; Zhou W; Jin X; Xu Z; Huang Y; Lin X; Nie H; Jiang Q BMC Cancer; 2021 Jun; 21(1):703. PubMed ID: 34130646 [TBL] [Abstract][Full Text] [Related]
8. Characteristics and prognostic value of potential dependency genes in clear cell renal cell carcinoma based on a large-scale CRISPR-Cas9 and RNAi screening database DepMap. Shi B; Ding J; Qi J; Gu Z Int J Med Sci; 2021; 18(9):2063-2075. PubMed ID: 33850477 [TBL] [Abstract][Full Text] [Related]
9. Supervised Learning and Multi-Omics Integration Reveals Clinical Significance of Inner Membrane Mitochondrial Protein (IMMT) in Prognostic Prediction, Tumor Immune Microenvironment and Precision Medicine for Kidney Renal Clear Cell Carcinoma. Chen CC; Chu PY; Lin HY Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240154 [TBL] [Abstract][Full Text] [Related]
10. Disulfidptosis-Related LncRNA Signatures for Prognostic Prediction in Kidney Renal Clear Cell Carcinoma. Feng K; Zhou S; Sheng Y; Lu K; Li C; Liu W; Kong H; Liu H; Mu Y; Zhang L; Zhang Q; Wang J Clin Genitourin Cancer; 2024 Aug; 22(4):102095. PubMed ID: 38833825 [TBL] [Abstract][Full Text] [Related]
11. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma. Chen L; Xiang Z; Chen X; Zhu X; Peng X Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362 [TBL] [Abstract][Full Text] [Related]
12. Comprehensive characterization of immune- and inflammation-associated biomarkers based on multi-omics integration in kidney renal clear cell carcinoma. Zhao E; Li L; Zhang W; Wang W; Chan Y; You B; Li X J Transl Med; 2019 May; 17(1):177. PubMed ID: 31133033 [TBL] [Abstract][Full Text] [Related]
13. Identification and validation of a two-gene metabolic signature for survival prediction in patients with kidney renal clear cell carcinoma. Guo X; Sun Z; Jiang S; Jin X; Wang H Aging (Albany NY); 2021 Mar; 13(6):8276-8289. PubMed ID: 33686951 [TBL] [Abstract][Full Text] [Related]
14. Identification of 4-genes model in papillary renal cell tumor microenvironment based on comprehensive analysis. Luo L; Zhou H; Su H BMC Cancer; 2021 May; 21(1):553. PubMed ID: 33993869 [TBL] [Abstract][Full Text] [Related]
15. Systematic analysis of survival-associated alternative splicing signatures in clear cell renal cell carcinoma. Chen T; Zheng W; Chen J; Lin S; Zou Z; Li X; Tan Z J Cell Biochem; 2020 Oct; 121(10):4074-4084. PubMed ID: 31886566 [TBL] [Abstract][Full Text] [Related]
16. Development and verification of a nomogram for prediction of recurrence-free survival in clear cell renal cell carcinoma. Chen Y; Jiang S; Lu Z; Xue D; Xia L; Lu J; Wang H; Xu L; Li L; Li G J Cell Mol Med; 2020 Jan; 24(2):1245-1255. PubMed ID: 31782902 [TBL] [Abstract][Full Text] [Related]
17. Prognostic Value of DNA Methylation-Driven Genes in Clear Cell Renal Cell Carcinoma: A Study Based on Methylation and Transcriptome Analyses. Hu M; Xie J; Hou H; Liu M; Wang J Dis Markers; 2020; 2020():8817652. PubMed ID: 32733620 [TBL] [Abstract][Full Text] [Related]
18. A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma. Zhan Y; Guo W; Zhang Y; Wang Q; Xu XJ; Zhu L Comput Math Methods Med; 2015; 2015():842784. PubMed ID: 26539246 [TBL] [Abstract][Full Text] [Related]
19. Integrated analysis of methylation-driven genes and pretreatment prognostic factors in patients with hepatocellular carcinoma. He D; Liao S; Cai L; Huang W; Xie X; You M BMC Cancer; 2021 May; 21(1):599. PubMed ID: 34034705 [TBL] [Abstract][Full Text] [Related]
20. N6‑methyladenosine RNA methylation regulators participate in malignant progression and have prognostic value in clear cell renal cell carcinoma. Zheng Z; Mao S; Guo Y; Zhang W; Liu J; Li C; Yao X Oncol Rep; 2020 May; 43(5):1591-1605. PubMed ID: 32323803 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]